BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9469361)

  • 41. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
    Motzer RJ; Mazumdar M; Bosl GJ; Bajorin DF; Amsterdam A; Vlamis V
    J Clin Oncol; 1996 Apr; 14(4):1098-105. PubMed ID: 8648363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
    Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch JR; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono JS; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols CR; Théodore C; Hartmann JT; Schmoll HJ; Kaye SB; Culine S; Droz JP; Mahé C
    J Clin Oncol; 2001 May; 19(10):2647-57. PubMed ID: 11352956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
    Vuky J; Bains M; Bacik J; Higgins G; Bajorin DF; Mazumdar M; Bosl GJ; Motzer RJ
    J Clin Oncol; 2001 Feb; 19(3):682-8. PubMed ID: 11157018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89.
    Göbel U; Schneider DT; Calaminus G; Jürgens H; Spaar HJ; Sternschulte W; Waag K; Harms D
    J Clin Oncol; 2001 Apr; 19(7):1943-50. PubMed ID: 11283126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis.
    Fedyanin M; Tryakin A; Bulanov A; Fainshtein I; Zakharova T; Matveev V; Garin A; Tjulandin S
    Urol Oncol; 2014 Jan; 32(1):32.e27-33. PubMed ID: 23628310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
    Fizazi K; Culine S; Droz JP; Kramar A; Théodore C; Ruffié P; Le Chevalier T
    J Clin Oncol; 1998 Feb; 16(2):725-32. PubMed ID: 9469363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
    Gilligan TD; Seidenfeld J; Basch EM; Einhorn LH; Fancher T; Smith DC; Stephenson AJ; Vaughn DJ; Cosby R; Hayes DF;
    J Clin Oncol; 2010 Jul; 28(20):3388-404. PubMed ID: 20530278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
    ; Lorch A; Beyer J; Bascoul-Mollevi C; Kramar A; Einhorn LH; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin KA; Lotz JP; Germa Lluch JR; Powles T; Kollmannsberger CK
    J Clin Oncol; 2010 Nov; 28(33):4906-11. PubMed ID: 20956623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome.
    Ogino H; Shibamoto Y; Takanaka T; Suzuki K; Ishihara S; Yamada T; Sugie C; Nomoto Y; Mimura M
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):803-8. PubMed ID: 15936563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89.
    Calaminus G; Bamberg M; Harms D; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Neuropediatrics; 2005 Apr; 36(2):71-7. PubMed ID: 15822019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96.
    Schneider DT; Calaminus G; Reinhard H; Gutjahr P; Kremens B; Harms D; Göbel U
    J Clin Oncol; 2000 Feb; 18(4):832-9. PubMed ID: 10673525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
    J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
    Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
    Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnosis and treatment of mediastinal teratoid tumors].
    Ito M; Miyake M; Mitsuoka A
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1361-70. PubMed ID: 2409924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.